ISGlobal Archives - Page 14 of 19 - El·lipse

28.10.2020

Citizen science to fight against air pollution

19.10.2020

Meet the people behind the PRBB live and without filters

Rafael Vilasanjuan, director of ISGlobal's Global Analysis and Development Department, is involved in the worldwide distribution of the Covid19 vaccine through the CovaxFacility platform.

09.10.2020

Rafa Vilasanjuan (ISGlobal): “We will have vaccines, but they will not be available to everyone within the first year”

ADHD and worsening memory in children could be associated Photo by Jerry Wang on Unsplash

01.10.2020

ADHD and childhood memory deficits, genetically linked

A study of 1,200 children analyzed the trajectory of weight up to the age of four and its relationship with lung function at age seven. Photo by Kelly Sikkema via Unsplash.

29.08.2020

Weight gain in the first years of life can affect lung function

Researchers at ISGlobal have studied the effects of night-time exposure to blue light. Photo by Wyron A via Unsplash.

12.08.2020

Night-time exposure to the light emitted by mobiles and white LEDs linked to higher colorectal cancer risk

The use of masks, hand washing and social distancing could prevent a second wave. Image by cottonbro (Pexels).

14.07.2020

Covid19: learning from the past to plan for the future

The findings provide further evidence that modifying environmental exposures early in life can limit the risk of obesity and associated complications. | Picture by Mohamed Hassan from Pixabay.

30.06.2020

Air pollution, smoking and built environment are associated with an increased risk of childhood obesity

Obesity is a complex disease that is becoming increasingly prevalent in society and the accompanying conditions have a very negative impact on the quality of life and life expectancy of those affected. | Picture by Colin Behrens from Pixabay.

03.06.2020

Chromosomal variants may explain the link between obesity and diseases such as asthma or diabetes

Picture by Federico Giampieri from Unsplash.

29.05.2020

Heat now more lethal than cold for people with respiratory diseases in Spain

PRBB residents at the 2019 OpenDay volunteers lunch.

29.05.2020

The PRBB remains stable regarding the latest demographic data

Ivermectin was recently shown to inhibit the replication of SARS-CoV-2 in vitro at very high doses, but this effect has not yet been studied in vivo. The new study will investigate this question in a randomised trial. | Picture by ISGlobal.

21.05.2020

New study to assess the efficacy of ivermectin against COVID-19